Current perspective – Trastuzumab-Reference-Cited by-同舟云学术

Current perspective – Trastuzumab

Published:2009-01 Issue:1 Volume:45 Page:12-18
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Hall Peter S.,Cameron David A.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference61 articles.

1. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene;Slamon;Science,1987

2. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer;Slamon;Science,1989

3. Detection and quantifation of HER-2/neu gene amplification in human breast cancer archival material using fluorescence in situ hybridization;Pauletti;Oncogene,1996

4. Overexpression of the c-erbB-2 protein in human breast tumor cell lines;Hynes;J Cell Biochem,1989

5. Trastuzumab: mechanism of action, resistance and future perspectives in HER2-overexpressing breast cancer;Valabrega;Ann Oncol,2007

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revolutionizing cancer care strategies: immunotherapy, gene therapy, and molecular targeted therapy;Molecular Biology Reports;2024-01-28

2. Therapeutic Protein-Based Vaccines;Protein-based Therapeutics;2023

3. Efficacy and Safety of Therapeutic Proteins;Protein-based Therapeutics;2023

4. The impact of HER2 overexpression on the miRNA and circRNA transcriptomes in two breast cell lines and their vesicles;Pharmacogenomics;2019-05

5. Blockade of CD112R and TIGIT signaling sensitizes human natural killer cell functions;Cancer Immunology, Immunotherapy;2017-06-16